KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to -$632.0 million.

  • Thermo Fisher Scientific's Cash from Financing Activities rose 4689.08% to -$632.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.4 billion, marking a year-over-year decrease of 1837.94%. This contributed to the annual value of -$6.8 billion for FY2024, which is 8752.07% down from last year.
  • According to the latest figures from Q3 2025, Thermo Fisher Scientific's Cash from Financing Activities is -$632.0 million, which was up 4689.08% from -$991.0 million recorded in Q2 2025.
  • Thermo Fisher Scientific's Cash from Financing Activities' 5-year high stood at $8.5 billion during Q4 2021, with a 5-year trough of -$4.9 billion in Q2 2021.
  • Over the past 5 years, Thermo Fisher Scientific's median Cash from Financing Activities value was -$991.0 million (recorded in 2025), while the average stood at -$440.4 million.
  • In the last 5 years, Thermo Fisher Scientific's Cash from Financing Activities skyrocketed by 1737959.18% in 2021 and then tumbled by 240657.89% in 2022.
  • Quarter analysis of 5 years shows Thermo Fisher Scientific's Cash from Financing Activities stood at $8.5 billion in 2021, then crashed by 71.76% to $2.4 billion in 2022, then plummeted by 159.72% to -$1.4 billion in 2023, then crashed by 156.72% to -$3.7 billion in 2024, then surged by 82.76% to -$632.0 million in 2025.
  • Its Cash from Financing Activities was -$632.0 million in Q3 2025, compared to -$991.0 million in Q2 2025 and -$102.0 million in Q1 2025.